Blog

How CAT-MH^® helped one practice save lives

In the world of behavioral health, every moment counts. When someone reaches out for help, there's often a narrow window of opportunity—one that can close quickly if the right support isn't available immediately. For Bernie Dyme, a licensed clinical social worker with over four decades of experience, finding ways to maximize that critical window became essential as his practice grew.

There is no shortage of studies on sensory processing and the interplay between sensory preferences and sensory environments on an individual’s health, well-being, and ability to perform tasks, but the research often fails to reflect lived sensory experiences. The connection between interoception — the perceptions of bodily signals and states — needs to be included in a comprehensive look at a person’s sensory patterns.

What if the young people involved in community violence were just individuals struggling with untreated mental health conditions? 

This question lies at the heart of groundbreaking research that's changing how we understand and address violence in our communities.

Dr. Michael Brook, associate professor at Northwestern University's Feinberg School of Medicine, has spent years studying this connection. His work reveals something most people don't realize: the majority of young people who become involved in community violence have significant histories of trauma, depression, hopelessness, and other mental health conditions that directly increase their risk.

Dr. Lisa Pellegrin, a licensed clinical psychologist in Tennessee, discovered exactly how to make this happen—and it's changing how she delivers care in her private practice.

What if you could spot undiagnosed ADHD in a 40-year-old father who came in for marriage counseling? Dr. Jared Minkel did exactly that—and it changed his patient's life. But first, the backstory...

The growing number of clinical trials and increasing number of drugs in the pipeline are reasons for optimism in the quest for new treatments for Alzheimer’s disease (AD). At the same time, there are concerns that many of the clinical assessments used to evaluate cognition are no longer fit for purpose.

Alzheimer’s researcher Jeffrey Cummings, MD, a neurologist and research professor at the University of Nevada, Las Vegas, notes, “The assessments often date from the 1970s and 1980s, when we had a much less thorough understanding of early disease presentation.” Digital testing offers a solution.

In a new episode of a Pearson-sponsored podcast series, “The Progress Profile: Alzheimer’s Research in Focus,” Cummings joined moderator John Harrison, Ph.D., CPsychol, CSci, AFBPsS, an associate professor at Alzheimercentrum, AUmc, Amsterdam, to share his thoughts on the role of digital testing in Alzheimer’s disease.